Investing Profile

Matias Serebrinsky(357)

VCFounderOperator

Mental health and psychedelic therapeutics investor. Cofounder and GP at PsyMed Ventures.

psymed.venturesSan Francisco Bay Area

Your Intro Paths to Matias Serebrinsky

Signal uses Gmail to reveal intro paths. Email content is never read.

Matias Serebrinsky's investing connections

16 Investors

Connected to Satya Patel (Homebrew), Aileen Lee (Cowboy Ventures), Morgan Beller (NFX), and 13 other investors on Signal.

Find Matias Serebrinsky on

Current Investing Position

PsyMed Ventures General Partner

Investment Range

$100K - $2.5M

Sweet Spot

$500K

Investments On Record

Matias Serebrinsky is on these Sector & Stage Rankings

Pharmaceuticals (Pre-seed)DeepTech (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Health IT (Pre-seed)Pharmaceuticals (Seed)DeepTech (Seed)Digital Health (Seed)BioTech (Seed)Health IT (Seed)DeepTech (Series A)Pharmaceuticals (Series A)Digital Health (Series A)BioTech (Series A)Health IT (Series A)Investors who were founders Investors who invested in female founders Investors who invested in diverse founders San Francisco Bay Area

Matias Serebrinsky's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Delix Therapeutics	Series ASep 2021$70M	$70M
Co-investors: Ken Belotsky (Negev Capital), Andrew Levin (RA Capital), Vasudev Bailey (Artis Ventures (AV))
Mindstate	Seed+Sep 2021$250K	$250K
Journey Clinical	SeedAug 2021$250K Pre-seedFeb 2021$150K	$12M
Co-investors: Ela Madej (Fifty Years), Rebecca Kaden (Union Square Ventures), Daniel Love (Beckley Waves), Mack Luby (Mystic Ventures), Edvard Engesæth
Beckley Psytech	Series BJun 2021$1	$80M £58M
Co-investors: Eric Brook (B Capital Group), Kunal Sethi (Prithvi Ventures), Ken Belotsky (Negev Capital), Stephen Hays (What If Ventures), Amy Kruse (Prime Movers Lab)
ATAI Life Sciences	Series DFeb 2021$3.6M Series COct 2020$130M	$690M
Co-investors: Peter Thiel (Founders Fund), Stephen Hays (What If Ventures), Martin Alexander Gershon (Endeavor Venture Funds), Christian Angermayer (Presight Capital), Jason Camm (Thiel Capital), Steve Jurvetson (Future Ventures), Maryanna Saenko (Future Ventures), Janice Bourque (Hercules Capital), Nico Wittenborn (Adjacent), Victor Douce (Brkfst Club), Ken Belotsky (Negev Capital), Miyuki Matsumoto (Aglae Ventures), Akshay Sriprasad
Maya Health	SeedOct 2020$100K	$100K
Co-investors: Mack Luby (Mystic Ventures)
TRIPP	Series ASep 2017$4M	$26M
Co-investors: Moritz Baier-Lentz (Lightspeed Venture Partners), Tim Chang (Mayfield), Malte Barth (BITKRAFT Ventures), Vijay Chattha (VSC Ventures), Ryan Zurrer (Vine Ventures (vine.vc)), Matt Mullenweg (Audrey Capital), Paul Palmieri (Grit Capital Partners), Robert Goldberg, Sahin Boydas, Ted Moskovitz

most interested in

Investing in psychedelic medicine and tech that elevates health & wellness. Focus areas: -Psychedelics & New Compounds -Neurotech & BCI -Precision Psychiatry -Digital Therapeutics

Matias Serebrinsky's Experience

Head of Inception (startup ecosystem) NVIDIA2016 - 2021

Cofounder CookUnity2014 - 2016

Investors who invest with Matias Serebrinsky